These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9716337)

  • 1. Basal cell carcinoma of the eyelid. Risk of recurrence according to adequacy of surgical margins.
    Sigurdsson H; Agnarsson BA
    Acta Ophthalmol Scand; 1998 Aug; 76(4):477-80. PubMed ID: 9716337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and histologic features of 141 primary basal cell carcinomas of the periocular region and their rate of recurrence after surgical excision].
    Spraul CW; Ahr WM; Lang GK
    Klin Monbl Augenheilkd; 2000 Oct; 217(4):207-14. PubMed ID: 11098454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Non-melanotic Tumors of the Eyelids Skin and Inner Corner - Basocellular Carcinoma].
    Furdová A; Horkovičová K; Babál P; Kobzová D; Ondrušová M
    Cesk Slov Oftalmol; 2015; 71(6):293-301. PubMed ID: 26782918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study and risk factors for recurrence of basal cell carcinoma of the eyelid: results of a Tunisian series and review of the literature].
    Knani L; Romdhane O; Ben Rayana N; Mahjoub H; Ben Hadj Hamida F
    J Fr Ophtalmol; 2014 Feb; 37(2):107-14. PubMed ID: 24486074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of excision of 1750 eyelid and periocular skin basal cell and squamous cell carcinomas by modified en face frozen section margin-controlled technique.
    Gayre GS; Hybarger CP; Mannor G; Meecham W; Delfanti JB; Mizono GS; Guerry TL; Chien JS; Sooy CD; Anooshian R; Simonds R; Pietila KA; Smith DW; Dayhoff DA; Engman E; Lacy J
    Int Ophthalmol Clin; 2009; 49(4):97-110. PubMed ID: 20348860
    [No Abstract]   [Full Text] [Related]  

  • 6. Minimum histological safety margins in periocular basal cell carcinoma.
    Sun MT; Figueira E; Huilgol SC; Selva D
    Br J Ophthalmol; 2014 May; 98(5):706. PubMed ID: 24457367
    [No Abstract]   [Full Text] [Related]  

  • 7. [Descriptive study on basal cell eyelid carcinoma].
    Pfeiffer MJ; Pfeiffer N; Valor C
    Arch Soc Esp Oftalmol; 2015 Sep; 90(9):426-31. PubMed ID: 25817947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal cell carcinomas of the eyelid: Results of an initial surgical management.
    Poignet B; Gardrat S; Dendale R; Lemaitre S; Lumbroso-Le Rouic L; Desjardins L; Cassoux N; Levy Gabriel C
    J Fr Ophtalmol; 2019 Dec; 42(10):1094-1099. PubMed ID: 31727330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant eyelid tumours in Taiwan.
    Wang JK; Liao SL; Jou JR; Lai PC; Kao SC; Hou PK; Chen MS
    Eye (Lond); 2003 Mar; 17(2):216-20. PubMed ID: 12640409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota.
    Cook BE; Bartley GB
    Ophthalmology; 1999 Apr; 106(4):746-50. PubMed ID: 10201597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic safety margin in basal cell carcinoma of the eyelid: correlation with recurrence rate.
    Auw-Haedrich C; Frick S; Boehringer D; Mittelviefhaus H
    Ophthalmology; 2009 Apr; 116(4):802-6. PubMed ID: 19232734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of eyelid sebaceous carcinomas.
    Dogru M; Matsuo H; Inoue M; Okubo K; Yamamoto M
    Ophthalmologica; 1997; 211(1):40-3. PubMed ID: 8958530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of basal cell carcinoma surgery of the eyelids].
    Steinkogler FJ; Scholda CD
    Fortschr Ophthalmol; 1991; 88(4):416-8. PubMed ID: 1786934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgical treatment of malignant eyelid tumors].
    Zieliński T; Pisera P; Siewiera I; Sporny S; Iljin A
    Pol Merkur Lekarski; 2013 Apr; 34(202):214-8. PubMed ID: 23745328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of periocular basal and squamous cell carcinoma: a series of 485 cases.
    Nemet AY; Deckel Y; Martin PA; Kourt G; Chilov M; Sharma V; Benger R
    Am J Ophthalmol; 2006 Aug; 142(2):293-7. PubMed ID: 16876511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Basalioma of the eyelid: rate and factors of recurrence after surgical therapy].
    Svetlosáková Z; Halás M; Krásnik V; Strmen P
    Cesk Slov Oftalmol; 2010 Oct; 66(4):171-5. PubMed ID: 21394970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors associated with relapse of eyelid basal cell carcinoma: results from a retrospective study of 142 patients.
    Fatigato G; Capitani S; Milani D; Grassilli S; Alameen AA; Candiani M; Riberti C; Galasso M; Previati M
    Eur J Dermatol; 2017 Aug; 27(4):363-368. PubMed ID: 28524055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical excision of periocular basal cell carcinomas.
    Taherian K; Shekarchian M; Atkinson PL
    Indian J Ophthalmol; 2007; 55(2):137-8. PubMed ID: 17322605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5 years review of periocular basal cell carcinoma and proposed follow-up protocol.
    Ho SF; Brown L; Bamford M; Sampath R; Burns J
    Eye (Lond); 2013 Jan; 27(1):78-83. PubMed ID: 23154501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors in the successful surgical management of basal cell carcinoma of the eyelids.
    Doxanas MT; Green WR; Iliff CE
    Am J Ophthalmol; 1981 Jun; 91(6):726-36. PubMed ID: 7246696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.